NIGHTSTARX LIMITED Revenue and Competitors
Estimated Revenue & Valuation
- NIGHTSTARX LIMITED's estimated annual revenue is currently $16.1M per year.
Employee Data
NIGHTSTARX LIMITED Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $58.9M | 293 | 6% | N/A | N/A |
#2 | $21.1M | 105 | 5% | N/A | N/A |
#3 | $113.4M | 564 | 1% | N/A | N/A |
#4 | $20.9M | 104 | -5% | N/A | N/A |
#5 | $37M | 184 | 9% | N/A | N/A |
#6 | $45.4M | 226 | -24% | N/A | N/A |
#7 | $16.1M | N/A | N/A | N/A | |
#8 | $69.7M | 347 | 0% | N/A | N/A |
#9 | $8M | 40 | 3% | N/A | N/A |
#10 | $25.5M | 127 | 28% | N/A | N/A |
What Is NIGHTSTARX LIMITED?
Nightstar Therapeutics plc (NASDAQ: NITE) is a leading clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases including choroideremia, X-linked retinitis pigmentosa and Best vitelliform macular dystrophy.
keywords:N/A
N/A
Total Funding
N/A
Number of Employees
$16.1M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
NIGHTSTARX LIMITED News
Besides the VILL, only a limited number of PRO instruments were designed to ... LinBioscience, NightStarX, Novartis, Optos, Pixium Vision,...
... Therapeutics Limited and its AAV2-based one-time investigational ... manufacturing and controls (CMC) for its NightstaRx Therapeutics...
Under the SME Scheme, our principal research subsidiary company, NightstaRx Limited, may be eligible to surrender the trading losses that